In pharmaceuticals, wrong decisions can not only cost a company revenue, but they can also cost people their lives. With stakes so high, it’s vital that pharmaceutical companies have robust systems and processes in place to accurately gather, analyze, and interpret data and turn it into actionable steps to solving health issues.

Suman Giri is the Global Head of Data Science of the Human Health Division at Merck, a biopharmaceutical research company that works to develop innovative health solutions for both people and animals. Suman joins the show today to share how Merck is using data to improve organizational decision-making, medical research outcomes, and how data science is transforming the pharmaceutical industry at scale. He also shares some of the biggest challenges facing the industry right now and what new trends are on the horizon.

#94 How Data Science Enables Better Decisions at Merck 39:38 Share

DataFramed

Shownotes Transcript

#94 How Data Science Enables Better Decisions at Merck